Akebia Therapeutics
AKBA
#7345
Rank
โ‚น40.49 B
Marketcap
โ‚น152.61
Share price
3.03%
Change (1 day)
-3.68%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚น40.49 Billion

As of December 2025 Akebia Therapeutics has a market cap of โ‚น40.49 Billion. This makes Akebia Therapeutics the world's 7345th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น40.49 B10.96%
2024โ‚น36.49 B87.68%
2023โ‚น19.44 B121.4%
2022โ‚น8.78 B-70.16%
2021โ‚น29.43 B-0.56%
2020โ‚น29.59 B-46.03%
2019โ‚น54.83 B21.33%
2018โ‚น45.19 B0.71%
2017โ‚น44.88 B65.54%
2016โ‚น27.11 B2.98%
2015โ‚น26.32 B75.19%
2014โ‚น15.02 B

End of Day market cap according to different sources

On Dec 24th, 2025 the market cap of Akebia Therapeutics was reported to be:

โ‚น39.30 Billion
by Nasdaq info icon info icon
โ‚น40.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น16.143 T 39,763.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น23.922 T 58,970.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚น44.939 T 110,868.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น80.23 B 98.13%๐Ÿ‡บ๐Ÿ‡ธ USA